 SAN FRANCISCO, May 6, 2021 PRNewswire -- Nektar Therapeutics Nasdaq: NKTR today reported financial results for the first quarter ended March 31, 2021. Cash and investments in marketable securities at March 31, 2021 were approximately 1.1 billion as compared to 1.2 billion at December 31, 2020. 